Surya Biru Murni Acetylene Tbk PT
IDX:SBMA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
124
179
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Surya Biru Murni Acetylene Tbk PT
Balance Sheet
Balance Sheet Decomposition
Surya Biru Murni Acetylene Tbk PT
| Current Assets | 40.2B |
| Cash & Short-Term Investments | 11.4B |
| Receivables | 23.8B |
| Other Current Assets | 5B |
| Non-Current Assets | 250.5B |
| PP&E | 249.4B |
| Other Non-Current Assets | 1.2B |
| Current Liabilities | 32.5B |
| Accounts Payable | 1.7B |
| Accrued Liabilities | 6B |
| Short-Term Debt | 15.5B |
| Other Current Liabilities | 9.3B |
| Non-Current Liabilities | 34.1B |
| Long-Term Debt | 19B |
| Other Non-Current Liabilities | 15.1B |
Balance Sheet
Surya Biru Murni Acetylene Tbk PT
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
2 415
|
2 111
|
1 779
|
23 099
|
8 304
|
4 752
|
|
| Cash |
2 415
|
2 111
|
1 779
|
23 099
|
8 304
|
4 752
|
|
| Total Receivables |
18 327
|
21 443
|
18 632
|
24 137
|
23 775
|
22 165
|
|
| Accounts Receivables |
16 789
|
19 604
|
17 926
|
23 652
|
23 431
|
21 871
|
|
| Other Receivables |
1 538
|
1 840
|
706
|
486
|
344
|
294
|
|
| Inventory |
4 958
|
4 857
|
4 229
|
4 645
|
6 026
|
3 590
|
|
| Other Current Assets |
1 633
|
2 431
|
6 518
|
3 706
|
3 068
|
1 177
|
|
| Total Current Assets |
27 333
|
30 842
|
31 158
|
55 588
|
41 173
|
31 685
|
|
| PP&E Net |
95 242
|
95 280
|
162 925
|
193 433
|
227 537
|
243 794
|
|
| PP&E Gross |
95 242
|
95 280
|
162 925
|
193 433
|
0
|
0
|
|
| Accumulated Depreciation |
56 092
|
60 407
|
57 741
|
60 239
|
0
|
0
|
|
| Other Long-Term Assets |
884
|
1 071
|
1 171
|
1 598
|
896
|
701
|
|
| Total Assets |
123 459
N/A
|
127 192
+3%
|
195 254
+54%
|
250 619
+28%
|
269 606
+8%
|
276 180
+2%
|
|
| Liabilities | |||||||
| Accounts Payable |
4 639
|
4 208
|
2 613
|
3 905
|
5 114
|
2 607
|
|
| Accrued Liabilities |
326
|
708
|
1 098
|
985
|
1 119
|
2 522
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
22 090
|
17 442
|
|
| Current Portion of Long-Term Debt |
29 047
|
29 776
|
29 608
|
25 957
|
3 977
|
5 080
|
|
| Other Current Liabilities |
325
|
848
|
1 255
|
1 807
|
507
|
1 109
|
|
| Total Current Liabilities |
34 337
|
35 540
|
34 574
|
32 653
|
32 807
|
28 760
|
|
| Long-Term Debt |
1 698
|
1 292
|
0
|
80
|
13 497
|
18 138
|
|
| Other Liabilities |
15 142
|
13 596
|
10 699
|
12 593
|
12 229
|
13 833
|
|
| Total Liabilities |
51 176
N/A
|
50 428
-1%
|
45 273
-10%
|
45 326
+0%
|
58 534
+29%
|
60 731
+4%
|
|
| Equity | |||||||
| Common Stock |
5 000
|
5 000
|
65 000
|
92 840
|
92 993
|
92 993
|
|
| Retained Earnings |
55 852
|
60 472
|
5 777
|
13 191
|
17 675
|
21 013
|
|
| Additional Paid In Capital |
11 294
|
11 294
|
11 294
|
29 196
|
29 395
|
29 395
|
|
| Other Equity |
136
|
3
|
67 909
|
70 066
|
71 010
|
72 049
|
|
| Total Equity |
72 282
N/A
|
76 764
+6%
|
149 980
+95%
|
205 293
+37%
|
211 073
+3%
|
215 449
+2%
|
|
| Total Liabilities & Equity |
123 459
N/A
|
127 192
+3%
|
195 254
+54%
|
250 619
+28%
|
269 606
+8%
|
276 180
+2%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
928
|
928
|
928
|
928
|
930
|
930
|
|
You don't have any saved screeners yet
